Last reviewed · How we verify
Luitpold Azacitidine — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Luitpold Azacitidine (Luitpold Azacitidine) — American Regent, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Luitpold Azacitidine TARGET | Luitpold Azacitidine | American Regent, Inc. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Luitpold Azacitidine CI watch — RSS
- Luitpold Azacitidine CI watch — Atom
- Luitpold Azacitidine CI watch — JSON
- Luitpold Azacitidine alone — RSS
Cite this brief
Drug Landscape (2026). Luitpold Azacitidine — Competitive Intelligence Brief. https://druglandscape.com/ci/luitpold-azacitidine. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab